{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:19:23Z","timestamp":1792113563933,"version":"4.4.0"},"reference-count":109,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ISCA Diagnostics Ltd."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Mucormycosis is a highly aggressive angio-invasive disease of humans caused by fungi in the zygomycete order, Mucorales. Though a number of different species can cause mucormycosis, the principal agent of the disease worldwide is Rhizopus arrhizus, which accounts for the majority of rhino-orbital-cerebral, pulmonary, and disseminated infections in immunocompromised individuals. It is also the main cause of life-threatening infections in patients with poorly controlled diabetes mellitus, and in corticosteroid-treated patients with SARS-CoV-2 infection, where it causes the newly described disease, COVID-19-associated mucormycosis (CAM). Diagnosis currently relies on non-specific CT, a lengthy and insensitive culture from invasive biopsy, and a time-consuming histopathology of tissue samples. At present, there are no rapid antigen tests for the disease that detect biomarkers of infection, and which allow point-of-care diagnosis. Here, we report the development of an IgG1 monoclonal antibody (mAb), KC9, which is specific to Rhizopus arrhizus var. arrhizus (syn. Rhizopus oryzae) and Rhizopus arrhizus var. delemar (Rhizopus delemar), and which binds to a 15 kDa extracellular polysaccharide (EPS) antigen secreted during hyphal growth of the pathogen. Using the mAb, we have developed a competitive lateral-flow device (LFD) that allows rapid (30 min) and sensitive (~50 ng\/mL running buffer) detection of the EPS biomarker, and which is compatible with human serum (limit of detection of ~500 ng\/mL) and bronchoalveolar lavage fluid (limit of detection of ~100 ng\/mL). The LFD, therefore, provides a potential novel opportunity for the non-invasive detection of mucormycosis caused by Rhizopus arrhizus.<\/jats:p>","DOI":"10.3390\/jof8070756","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T10:36:56Z","timestamp":1658399816000},"page":"756","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Development of a Monoclonal Antibody and a Serodiagnostic Lateral-Flow Device Specific to Rhizopus arrhizus (Syn. R. oryzae), the Principal Global Agent of Mucormycosis in Humans"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-6734","authenticated-orcid":false,"given":"Genna E.","family":"Davies","sequence":"first","affiliation":[{"name":"ISCA Diagnostics Ltd., B12A, Hatherly Laboratories, Prince of Wales Road, Exeter EX4 4PS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6213-3130","authenticated-orcid":false,"given":"Christopher R.","family":"Thornton","sequence":"additional","affiliation":[{"name":"MRC Centre for Medical Mycology, Geoffrey Pope Building, University of Exeter, Stocker Road, Exeter EX4 4QD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.aambs.2019.10.003","article-title":"Detection of the \u2018big five\u2019 mold killers of humans: Aspergillus, Fusarium, Lomentospora, Scedosporium and Mucormycetes","volume":"110","author":"Thornton","year":"2020","journal-title":"Adv. Appl. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.00036-09","article-title":"The spectrum of zygomycete species identified in clinically significant specimens in the United States","volume":"47","author":"Alvarez","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/myc.12233","article-title":"Mucormycosis in children: A study of 22 cases in a Mexican hospital","volume":"57","author":"Bonifaz","year":"2014","journal-title":"Mycoses"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/jinf.2001.0831","article-title":"Ten years\u2019 experience in Zygomycosis at a tertiary care centre in India","volume":"42","author":"Chakrabarti","year":"2001","journal-title":"J. Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"101203","DOI":"10.1016\/j.mycmed.2021.101203","article-title":"First report of COVID-19-assciated rhino-orbital-cerebral mucormycosis in paediatric patients with type 1 diabetes mellitus","volume":"31","author":"Diwakar","year":"2021","journal-title":"J. Med. Mycol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jpids\/pix107","article-title":"Mucormycosis in children: Review and recommendations for management","volume":"7","author":"Francis","year":"2018","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Prakash, H., and Chakrabarti, A. (2019). Global epidemiology of Mucormycosis. J. Fungi, 5.","DOI":"10.3390\/jof5010026"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Prakash, H., and Chakrabarti, A. (2021). Epidemiology of mucormycosis in India. Microorganisms, 9.","DOI":"10.3390\/microorganisms9030523"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/mmy\/myy060","article-title":"A prospective multicentre study on mucormycosis in India: Epidemiology, diagnosis, and treatment","volume":"57","author":"Prakash","year":"2019","journal-title":"Med. Mycol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: A review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/j.1469-0691.2010.03456.x","article-title":"Zygomycosis in Europe: Analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007","volume":"17","author":"Skiada","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"n1705","DOI":"10.1136\/bmj.n1705","article-title":"Black fungus: Paranasal mucormycosis","volume":"374","author":"Almeida","year":"2021","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1469-0691.2009.02982.x","article-title":"Outbreaks of zygomycosis in hospitals","volume":"15","author":"Antoniadou","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chikley, A., Ben-Ami, R., and Kontoyiannis, D.P. (2019). Mucormycosis of the central nervous system. J. Fungi, 5.","DOI":"10.3390\/jof5030059"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/mmy\/myx017","article-title":"Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases","volume":"56","author":"Walsh","year":"2018","journal-title":"Med. Mycol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1590\/S0037-86822011000200027","article-title":"Rhinocerebral zygomycosis in a diabetic patient","volume":"44","author":"Nery","year":"2011","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mycmed.2013.04.002","article-title":"Rhinocerebral mucormycosis due to Rhizopus oryzae in a diabetic patient: A case report","volume":"23","author":"Erami","year":"2013","journal-title":"J. Mycol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5314\/wjd.v8.i1.1","article-title":"Rhinocerebral mucormycosis caused by Rhizopus oryzae in a patient with acute myeloid leukemia","volume":"8","author":"Feng","year":"2020","journal-title":"World J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11046-019-00392-1","article-title":"From the pharynx to the brain: A case of rapidly progressing mucormycosis","volume":"184","author":"Jiang","year":"2019","journal-title":"Mycopathologia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.mmcr.2021.03.005","article-title":"Successful treatment of Rhizopus arrhizus rhino-orbital-cerebral mucormycosis with isavuconazole salvage therapy following extensive debridement","volume":"32","author":"Miller","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"944.e9","DOI":"10.1016\/j.cmi.2019.11.021","article-title":"A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India","volume":"26","author":"Patel","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1093\/cid\/cir868","article-title":"Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis)","volume":"54","author":"Walsh","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/ofid\/ofaa552","article-title":"Isolated cerebral mucormycosis in immunocompetent adults who inject drugs: Case reports and systematic review of the literature","volume":"7","author":"Meyerowitz","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"ofaa646","DOI":"10.1093\/ofid\/ofaa646","article-title":"Mucormycosis in hematopoietic cell transplant recipients and in patients with hematological malignancies in the era of new antifungal agents","volume":"8","author":"Miller","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_26","first-page":"648","article-title":"Disseminated infection with multiple cold abscesses caused by Rhizopus arrhizus in an immunocompetent girl","volume":"27","author":"Rehman","year":"2017","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"ref_27","first-page":"562","article-title":"Primary cutaneous mucormycosis due to Rhizopus arrhizus in an 8-year-old girl","volume":"109","year":"2018","journal-title":"Actas Dermosifiliogr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India: Experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad. Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcrc.2019.02.005","article-title":"Epidemiology and clinical outcomes of invasive mould infections in Indian intensive care units (FISF study)","volume":"15","author":"Chakrabarti","year":"2019","journal-title":"J. Crit. Care"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"746","DOI":"10.5946\/ce.2020.180","article-title":"Rare and fatal gastrointestinal mucormycosis (zygomycosis) in a COVID-19 patient: A case report","volume":"53","author":"Ribeiro","year":"2020","journal-title":"Clin. Endosc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mmcr.2014.11.003","article-title":"An unusual ulcer: A case of cutaneous mucormycosis caused by Rhizopus oryzae","volume":"7","author":"Gardiner","year":"2015","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7815","DOI":"10.1128\/AAC.01437-15","article-title":"VT-1161 protects immunosuppressed mice from Rhizopus arrhizus var. arrhizus infection","volume":"59","author":"Gabremariam","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.mmcr.2015.12.004","article-title":"Ventriculitis due to infection by Rhizopus arrhizus","volume":"10","author":"Hagel","year":"2015","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mycormycosis: A systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/1346-8138.12715","article-title":"Disseminated mucormycosis due to Rhizopus oryzae diagnosed by skin biopsy","volume":"42","author":"Kanemaru","year":"2014","journal-title":"J. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e000984","DOI":"10.1099\/jmmcr.0.000984","article-title":"Rhinocerebral mucormycosis in a patient with pre-B cell acute lymphoblastic leukaemia: PCR identifying Rhizopus oryzae from culture-negative tissue specimens","volume":"1","author":"Keisling","year":"2014","journal-title":"JMM Case Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11046-013-9654-z","article-title":"Gangrenous cutaneous mucormycosis caused by Rhizopus oryzae: A case report and review of primary cutaneous mucormycosis in China over past 20 years","volume":"176","author":"Li","year":"2013","journal-title":"Mycopathologia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1086\/508277","article-title":"Outbreak of cutaneous Rhizopus arrhizus infection associated with Karya ostomy bags","volume":"43","author":"Burwell","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11046-017-0158-0","article-title":"Rhizopus arrhizus invasive infection due to self-inflicted scratch injuries in a diabetic patient with non-ketotic acidosis","volume":"182","author":"Mercier","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Krishna, V., Bansal, N., Morjaria, J., and Kaul, S. (2022). COVID-19-associated pulmonary mucormycosis. J. Fungi, 8.","DOI":"10.3390\/jof8070711"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis","volume":"54","author":"Rammaert","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/ijd.IJD_551_18","article-title":"Zygomycosis of the scalp caused by Rhizopus oryzae presenting as kerion in an immunocompetent child","volume":"64","author":"Rao","year":"2019","journal-title":"Indian J. Dermatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11046-016-0084-6","article-title":"Primary cutaneous mucormycosis caused by Rhizopus oryzae: A case report and review of literature","volume":"182","author":"Arenas","year":"2017","journal-title":"Mycopathologia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/ijccm.IJCCM_343_17","article-title":"Primary cutaneous mucormycosis in a trauma patient with Morel-Lavall\u00e9e lesion","volume":"22","author":"Singla","year":"2018","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Song, Y., Qiao, J., Giovanni, G., Liu, G., Yang, H., Wu, J., and Chen, J. (2017). Mucormycosis in renal transplant recipients: Review of 174 reported cases. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2381-1"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4269\/ajtmh.21-0359","article-title":"COVID-19 associated rhinosinusitis mucormycosis due to Rhizopus oryzae: A rare but potentially fatal infection occurring after treatment with corticosteroids","volume":"105","author":"Tabarsi","year":"2021","journal-title":"Am. J. Trp. Med. Hyg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1128\/jcm.34.10.2585-2587.1996","article-title":"Gastric mucormycosis due to Rhizopus oryzae in a renal transplant recipient","volume":"34","author":"Winkler","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/myc.13256","article-title":"The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis","volume":"64","author":"Ahmadikia","year":"2021","journal-title":"Mycoses"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e13652","DOI":"10.1111\/tid.13652","article-title":"Mucormycosis associated with COVID-19 in two kidney transplant patients","volume":"23","author":"Arana","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"ref_50","first-page":"2100510","article-title":"Case series of four secondary mucormycosis infections in COVID-19 patients, the Netherlands, December 2020 to May 2021","volume":"26","author":"Buil","year":"2021","journal-title":"Euro. Serveill."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.fbr.2021.09.003","article-title":"The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID-19","volume":"38","author":"Ghosh","year":"2021","journal-title":"Fungal Biol. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"103080","DOI":"10.1016\/j.amjoto.2021.103080","article-title":"The impact of COVID-19 outbreak on the incidence of acute invasive fungal rhinosinusitis","volume":"42","author":"Ismaiel","year":"2021","journal-title":"Am. J. Otolaryngol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"101125","DOI":"10.1016\/j.mycmed.2021.101125","article-title":"Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient\u2014Case report and review of the literature","volume":"31","author":"Khatri","year":"2021","journal-title":"J. Med. Mycol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"105957","DOI":"10.1016\/j.ijscr.2021.105957","article-title":"Sino-orbital mucormycosis in a COVID-19 patient: A case report","volume":"82","author":"Maini","year":"2021","journal-title":"Int. J. Surg. Case Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s15010-020-01561-x","article-title":"A challenging complication following SARS-CoV-2 infection: A case report of pulmonary mucormycosis","volume":"49","author":"Pasero","year":"2021","journal-title":"Infection"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e241663","DOI":"10.1136\/bcr-2021-241663","article-title":"COVID-19 triggering mucormycosis in a susceptible patient: A new phenomenon in the developing world?","volume":"14","author":"Revannavar","year":"2021","journal-title":"BMJ Case Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e00094-21","DOI":"10.1128\/CMR.00094-21","article-title":"Pathogenesis of respiratory viral and fungal coinfections","volume":"35","author":"Salazar","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s15010-021-01670-1","article-title":"COVID-19 and mucormycosis superinfection: The perfect storm","volume":"49","author":"Alhumaid","year":"2021","journal-title":"Infection"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3126\/nje.v11i2.37342","article-title":"Mucormycosis and COVID-19 an epidemic in a pandemic","volume":"11","author":"Banerjee","year":"2021","journal-title":"Nepal J. Epidemiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chander, J., Kaur, M., Singla, N., Punia, R.P.S., Singhal, S.K., Attri, A.K., Alastruey-Izquierdo, A., Stchigel, A.M., Cano-Lira, J.F., and Guarro, J. (2018). Mucormycosis: Battle with the deadly enemy over a five-year period in India. J. Fungi, 4.","DOI":"10.3390\/jof4020046"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11046-021-00528-2","article-title":"Coronavirus disease (COVID-19) associated mucormycosis (CAM): Case report and systematic review of literature","volume":"186","author":"Garg","year":"2021","journal-title":"Mycopathologia"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Mohammadi, F., Badri, M., Safari, S., and Hemmat, N. (2021). A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: A systematic review of literature and current update. BMC Infect. Dis., 21.","DOI":"10.1186\/s12879-021-06625-3"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s11046-021-00584-8","article-title":"Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world","volume":"186","author":"Muthu","year":"2021","journal-title":"Mycopathologia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijmmb.2021.05.009","article-title":"Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India","volume":"39","author":"Nehara","year":"2021","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/myc.13335","article-title":"ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"Rudramurthy","year":"2021","journal-title":"Mycoses"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India\u2014Collaborative OPAI-IJO study on mucormycosis in COVID-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J. Ophthalmol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"102148","DOI":"10.1016\/j.tmaid.2021.102148","article-title":"COVID-19-associated mucormycosis: Case report and systematic review","volume":"44","author":"Dilek","year":"2021","journal-title":"Travel Med. Infect Dis."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Skiada, A., Pavlaes, I., and Drogari-Apiranthitou, M. (2020). Epidemiology and diagnosis of mucormycosis: An update. J. Fungi, 6.","DOI":"10.3390\/jof6040265"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1469-0691.12466","article-title":"Why is mucormycosis more difficult to cure than more common mycoses?","volume":"20","author":"Katragkou","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Lackner, N., Posch, W., and Lass-Fl\u00f6rl, C. (2021). Microbiological and molecular diagnosis of mucormycosis: From old to new. Microorganisms, 9.","DOI":"10.3390\/microorganisms9071518"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Weiss, Z.F., Leon, A., and Koo, S. (2021). The evolving landscape of fungal diagnostics, current and emerging microbiological approaches. J. Fungi, 7.","DOI":"10.3390\/jof7020127"},{"key":"ref_73","first-page":"20499361211034266","article-title":"Point of care tests for invasive fungal infections: A blue print for increasing availability in Africa","volume":"8","author":"Osaigbovo","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1099\/jmm.0.000091","article-title":"Differentiation of clinically relevant mucorales Rhizopus microsporus and R. arrhizus by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)","volume":"64","author":"Dolatabadi","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1128\/jcm.26.9.1861-1863.1988","article-title":"Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis","volume":"26","author":"Padhye","year":"1988","journal-title":"J. Clin. Microbiol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Talbot, N.J. (2001). Immunological Methods for Fungi. Molecular and Cellular Biology of Filamentous Fungi: A Practical Approach, Oxford University Press. [1st ed.].","DOI":"10.1093\/oso\/9780199638383.001.0001"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9975(08)80271-X","article-title":"Immunohistochemical identification of aetiological agents of systemic bovine zygomycosis","volume":"110","author":"Jensen","year":"1994","journal-title":"J. Comp. Path."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/030098589603300207","article-title":"Immunohistochemical diagnosis of systemic bovine zygomycosis by murine monoclonal antibodies","volume":"33","author":"Jensen","year":"1996","journal-title":"Vet. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1096-9896(199701)181:1<100::AID-PATH100>3.0.CO;2-O","article-title":"The use of immunohistochemistry to improve sensitivity and specificity in the diagnosis of systemic mycoses in patients with haematological malignancies","volume":"181","author":"Jensen","year":"1997","journal-title":"J. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Potenza, L., Vallerini, D., Barozzi, P., Riva, G., Gilioli, A., Forghieri, F., Candoni, A., Cesaro, S., Quadrelli, C., and Maertens, J. (2016). Mucorales-specific T cells in patients with hematologic malignancies. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149108"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/mmy\/myw146","article-title":"Identification of a novel Rhizopus-specific antigen by screening with a signal sequence trap and evaluation as a possible diagnostic marker of mucormycosis","volume":"55","author":"Sato","year":"2017","journal-title":"Med. Mycol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/mmy\/myaa001","article-title":"Detection of Rhizopus-specific antigen in human and murine serum and bronchoalveolar lavage","volume":"58","author":"Shibata","year":"2020","journal-title":"Med. Mycol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e00094-18","DOI":"10.1128\/mSphere.00094-18","article-title":"Conservation of mannan synthesis in fungi of the zygomycota and ascomycota reveals a broad diagnostic target","volume":"3","author":"Hubbard","year":"2018","journal-title":"mSphere"},{"key":"ref_84","unstructured":"Orne, C., Burnham-Marusich, A., Baldin, C., Gebremariam, T., Ibrahim, A., Kvam, A., and Kozel, T. (2018, January 21\u201324). Cell wall fucomannan is a biomarker for diagnosis of invasive murine mucormycosis. Proceedings of the 28th ECCMID, Madrid, Spain."},{"key":"ref_85","first-page":"125","article-title":"Rhizopus arrhizus and Fusarium solani concomitant infection in an immunocompromised host","volume":"181","author":"Ibrahim","year":"2015","journal-title":"Mycopathologia"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Ram\u00edrez-Hinojosa, J.P., Medrano-Ahumada, S., Arenas, R., Bravo-Escobar, A., Paraguirre-Mart\u00ednez, S., Xicohtencatl-Cortes, J., Mart\u00ednez-Herrera, E., and Hern\u00e1ndez-Castro, R. (2021). Fungal invasive co-infection due to Aspergillus fumigatus and Rhizopus arrhizus: A rhino-orbital presentation. J. Fungi, 7.","DOI":"10.3390\/jof7121096"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mmcr.2021.03.006","article-title":"Pulmonary aspergillosis and mucormycosis in a patient with COVID-19","volume":"32","author":"Johnson","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Luckowitsch, M., Rudolph, H., Bochennek, K., Porto, L., and Lehrnbecher, T. (2021). Central nervous system mold infections in children with hematological malignancies: Advances in diagnosis and management and treatment. J. Fungi, 7.","DOI":"10.3390\/jof7030168"},{"key":"ref_89","first-page":"DD01","article-title":"Exophiala jeanselmei and Rhizopus oryzae co-infection post renal transplant","volume":"13","author":"Meena","year":"2019","journal-title":"J. Clin. Diagn. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00405-008-0692-y","article-title":"Rhino-orbital-cerebral mucormycosis and aspergillosis: Differential diagnosis and treatment","volume":"266","author":"Arndt","year":"2009","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"P1230","DOI":"10.1016\/j.cmi.2021.02.005","article-title":"Serology anno 2021-fungal infections: From invasive to chronic","volume":"27","author":"Samardzic","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3324\/haematol.2012.065110","article-title":"Diagnosis and treatment of mucormycosis in patients with hematological malignancies: Guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3)","volume":"98","author":"Skiada","year":"2013","journal-title":"Haematologica"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e00136-19","DOI":"10.1128\/JCM.00136-19","article-title":"Evaluation of a novel Aspergillus antigen enzyme-linked immunosorbent assay","volume":"57","author":"Dichtl","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1515\/cclm-2016-0194","article-title":"Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum and immunoglobulin free light chains (FLC): From inception of a new near-patient FLC screening tool","volume":"55","author":"Campbell","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.aca.2018.02.039","article-title":"A competitive lateral flow assay for the detection of tenofivir","volume":"1017","author":"Pratt","year":"2018","journal-title":"Anal. Chim. Acta"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Bever, C.S., Adams, C.A., Hnasko, R.M., Cheng, L.W., and Stanker, L.H. (2020). Lateral flow immunoassay (LFIA) for the detection of lethal amatoxins in mushrooms. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0231781"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/09540105.2019.1708272","article-title":"Simultaneous and rapid detection of carbofuran and 3-hydroxy-carbofuran in water samples and pesticide preparation using lateral-flow immunochromatographic assay","volume":"31","author":"Lan","year":"2020","journal-title":"Food Agric. Immunol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1094\/PDIS-10-15-1211-RE","article-title":"Field evaluation of a competitive lateral-flow assay for detection of Alternaria brassicae in vegetable brassica crops","volume":"100","author":"Wakeham","year":"2016","journal-title":"Plant Dis."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Walther, G., Wagner, L., and Kurzai, O. (2019). Updates on the taxonomy of mucorales with an emphasis on clinically important taxa. J. Fungi, 5.","DOI":"10.3390\/jof5040106"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3934\/microbiol.2020018","article-title":"Six decades of lateral flow immunoassay: From determining metabolic markers to diagnosing COVID-19","volume":"6","author":"Andryukov","year":"2020","journal-title":"AIMS Microbiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e1783","DOI":"10.1093\/cid\/ciaa1667","article-title":"The importance of quantitative results of a lateral flow Aspergillus assay: The significant impact on specificity","volume":"73","author":"Misulka","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e1784","DOI":"10.1093\/cid\/ciaa1670","article-title":"Reply to Mikulska et al","volume":"73","author":"Jenks","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1439-0450.1993.tb00109.x","article-title":"Experimental systemic bovine zygomycosis with reference to pathology and secretion of antigen in urine","volume":"40","author":"Jensen","year":"1993","journal-title":"J. Vet. Med. B"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1128\/CVI.00068-08","article-title":"Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis","volume":"15","author":"Thornton","year":"2008","journal-title":"Clin. Vacc. Immunol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/mmy\/myz079","article-title":"Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicentre study","volume":"58","author":"Mercier","year":"2020","journal-title":"Med. Mycol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1093\/cid\/cir880","article-title":"A global analysis of mucormycosis in France: The RetroZygo study (2005\u20132007)","volume":"54","author":"Laternier","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Pana, Z.D., Seidel, D., Skiada, A., Groll, A.H., Petrikkos, G., Cornely, O.A., and Roilides, E. (2016). Invasive mucormycosis in children: An epidemiological study in European and non-European countries based on two registries. BMC Infect. Dis., 16.","DOI":"10.1186\/s12879-016-2005-1"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/myc.12243","article-title":"Mucormycosis in India: Unique features","volume":"57","author":"Chakrabarti","year":"2014","journal-title":"Mycoses"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2666-5247(21)00237-8","article-title":"The emergence of COVID-19 associated mucormycosis: A review of cases from 18 countries","volume":"3","author":"Hoenigl","year":"2022","journal-title":"Lancet Microbe"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/7\/756\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:55:51Z","timestamp":1760140551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/7\/756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,21]]},"references-count":109,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jof8070756"],"URL":"https:\/\/doi.org\/10.3390\/jof8070756","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,21]]}}}